{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:35:51Z","timestamp":1787502951799,"version":"build-2736575974"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007102","name":"Zagazig University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007102","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study aimed to investigate the association between XRCC1 Arg399Gln and Arg194Trp single nucleotide polymorphisms (SNPs) and the risk and severity of polyneuropathy (DPN) in patients with type 2 diabetes mellitus (T2DM). The genotyping of SNPs was achieved in 732 contributors, including diabetic subjects with and without polyneuropathy and controls, using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). In addition, by using advanced statistical techniques, including machine learning methodologies, to analyze the data.The results indicated a significant link between both SNPs and DPN risk under both codominant and dominant models, respectively, with the A and T alleles as risk variants. Haplotype analysis further established the A-T haplotype as a prominent risk factor. The disease severity was associated with the 399\u00a0A\/A and combined (G\/A\u2009+\u2009A\/A) genotypes, as well as the 194\u00a0C\/T and combined (C\/T\u2009+\u2009T\/T) genotypes. In advanced DPN stages, random Forest (RF) highlighted both XRCC1 SNPs, and disease duration as the top three contributing factors. SHAP analysis corroborated the 194\u00a0C\/T genotype of and the 399\u00a0A\/A genotype were strongly linked to severe disease manifestations, particularly when coexisting with prolonged illness duration, advanced age, elevated HDL, and reduced LDL levels. Our findings substantiate the association of XRCC1 Arg399Gln and Arg194Trp SNPs with both susceptibility to and progression of DPN in T2DM patients. The integration of machine learning methodologies augments clinical decision-making by refining diagnostic precision and facilitating personalized treatment strategies.<\/jats:p>","DOI":"10.1038\/s41598-026-35213-1","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:36:50Z","timestamp":1770143810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic polymorphisms in DNA repair gene XRCC1 and the risk of diabetic polyneuropathy"],"prefix":"10.1038","volume":"16","author":[{"given":"Noha A.","family":"Hashim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatim A.","family":"El-Baz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahraa I. Abo","family":"Afya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagar F.","family":"Gouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha M.","family":"Bakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"35213_CR1","doi-asserted-by":"publisher","first-page":"1265372","DOI":"10.3389\/fendo.2023.1265372","volume":"14","author":"J Zhu","year":"2024","unstructured":"Zhu, J. et al. Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Front. Endocrinol. (Lausanne). 14, 1265372 (2024).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"35213_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/japplphysiol.00733.2015","volume":"121","author":"MD Allen","year":"2016","unstructured":"Allen, M. D., Doherty, T. J., Rice, C. L. & Kimpinski, K. Physiology in medicine: neuromuscular consequences of diabetic neuropathy. J. Appl. Physiol. 121 (1), 1\u20136 (2016).","journal-title":"J. Appl. Physiol."},{"key":"35213_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/164_2022_585","volume":"274","author":"J R\u00f8ikjer","year":"2022","unstructured":"R\u00f8ikjer, J. & Ejskjaer, N. Diabetic peripheral neuropathy. Handb. Exp. Pharmacol. 274, 309\u2013328 (2022).","journal-title":"Handb. Exp. Pharmacol."},{"issue":"1","key":"35213_CR4","first-page":"141","volume":"1","author":"A Al Washali","year":"2014","unstructured":"Al Washali, A., Azuhairi, A., Hejar, A. & Amani, Y. Prevalence and associated risk factors of diabetic peripheral neuropathy among diabetic patients in National center of diabetes in Yemen. Int. J. Public. Health Clin. Sci. 1 (1), 141\u2013150 (2014).","journal-title":"Int. J. Public. Health Clin. Sci."},{"issue":"1","key":"35213_CR5","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.2147\/DMSO.S364933","volume":"15","author":"N Alshammari","year":"2022","unstructured":"Alshammari, N. et al. Evaluation of risk factors for diabetic peripheral neuropathy among Saudi type 2 diabetic patients with longer duration of diabetes. Diabetes Metab. Syndr. Obes. 15 (1), 3007\u20133014 (2022).","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"1","key":"35213_CR6","first-page":"1","volume":"19","author":"C Hicks","year":"2019","unstructured":"Hicks, C. & Selvin, E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr. Diabetes Rep. 19 (1), 1\u20138 (2019).","journal-title":"Curr. Diabetes Rep."},{"issue":"12","key":"35213_CR7","first-page":"1578","volume":"40","author":"L Qin","year":"2019","unstructured":"Qin, L. et al. Prevalence and risk factors of diabetic peripheral neuropathy in Chinese communities. Zhonghua Liu Xing Bing Xue Za Zhi. 40 (12), 1578\u20131584 (2019).","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"35213_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s13410-020-00885-6","volume":"41","author":"A Jasmine","year":"2021","unstructured":"Jasmine, A. et al. Prevalence of peripheral neuropathy among type 2 diabetes mellitus patients in a rural health centre in South India. Int. J. Diabetes Dev. Ctries. 41, 293\u2013300 (2021).","journal-title":"Int. J. Diabetes Dev. Ctries."},{"key":"35213_CR9","doi-asserted-by":"crossref","unstructured":"Amour, A. et al. Prevalence, patterns, and factors associated with peripheral neuropathies among diabetic patients at tertiary Hospital in the Kilimanjaro Region: descriptive cross-sectional study from north-eastern Tanzania. Int. J. Endocrinol. 5404781 (2019). (2019).","DOI":"10.1155\/2019\/5404781"},{"issue":"1","key":"35213_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-018-6374-9","volume":"19","author":"S Garoushi","year":"2019","unstructured":"Garoushi, S., Johnson, M. I. & Tashani, O. A. A cross-sectional study to estimate the point prevalence of painful diabetic neuropathy in Eastern Libya. BMC Public. Health. 19 (1), 1\u20137 (2019).","journal-title":"BMC Public. Health"},{"issue":"1","key":"35213_CR11","first-page":"2","volume":"113","author":"N Elmagboul","year":"2020","unstructured":"Elmagboul, N. Prevalence and associated risk factors of peripheral neuropathy in diabetic patients attending the primary health care centers in Khartoum locality, Khartoum State, Sudan at 2019. J. Diabetes Res. Reviews Rep. 113 (1), 2\u20137 (2020).","journal-title":"J. Diabetes Res. Reviews Rep."},{"issue":"1","key":"35213_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12902-022-01167-4","volume":"22","author":"L Owolabi","year":"2022","unstructured":"Owolabi, L. et al. Magnitude of diabetic peripheral neuropathy in Saudi arabia: a systematic review and meta-analysis. BMC Endocr. Disord. 22 (1), 266 (2022).","journal-title":"BMC Endocr. Disord"},{"issue":"4","key":"35213_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2174\/1573399815666190226150402","volume":"15","author":"F Amara","year":"2019","unstructured":"Amara, F. et al. Review of diabetic polyneuropathy: pathogenesis, diagnosis and management according to the consensus of Egyptian experts. Curr. Diabetes Rev. 15 (4), 340\u2013345 (2019).","journal-title":"Curr. Diabetes Rev."},{"issue":"9","key":"35213_CR14","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.3390\/ijms22094887","volume":"22","author":"M Jankovic","year":"2021","unstructured":"Jankovic, M. et al. Genetic and epigenomic modifiers of diabetic neuropathy. Int. J. Mol. Sci. 22 (9), 4887 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"35213_CR15","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1007\/s12035-023-03342-7","volume":"60","author":"Q Lin","year":"2023","unstructured":"Lin, Q. et al. Oxidative stress in diabetic peripheral neuropathy: pathway and mechanism-based treatment. Mol. Neurobiol. 60 (8), 4574\u20134594 (2023).","journal-title":"Mol. Neurobiol."},{"key":"35213_CR16","doi-asserted-by":"publisher","first-page":"1112363","DOI":"10.3389\/fendo.2023.1112363","volume":"14","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications. Front. Endocrinol. (Lausanne). 14, 1112363 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"35213_CR17","first-page":"24","volume":"729","author":"A Kumar","year":"2012","unstructured":"Kumar, A., Pan, M. C., Singh, H. S. & Khandelwal, S. Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in North Indian population. Mutat. Res. 729, 24\u201334 (2012).","journal-title":"Mutat. Res."},{"issue":"1","key":"35213_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","volume":"6","author":"R Huang","year":"2021","unstructured":"Huang, R. & Zhou, P. K. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal. Transduct. Target. Ther. 6 (1), 254 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"35213_CR19","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1186\/s12885-021-08979-y","volume":"21","author":"Y Zheng","year":"2021","unstructured":"Zheng, Y. et al. X-ray repair cross-complementing protein 1 (XRCC1) loss promotes \u03b2-lapachone \u2013induced apoptosis in pancreatic cancer cells. BMC Cancer. 21 (1), 1234 (2021).","journal-title":"BMC Cancer"},{"issue":"2","key":"35213_CR20","first-page":"125","volume":"10","author":"MC Stern","year":"2001","unstructured":"Stern, M. C., Umbach, D. M., Van Gils, C. H., Lunn, R. M. & Taylor, J. A. DNA Rapair gene XRCC1 polymorphisms, smoking and bladder cancer risk cancer epidemiol. Biomark. Prev. 10 (2), 125\u2013131 (2001).","journal-title":"Biomark. Prev."},{"issue":"2","key":"35213_CR21","first-page":"AC06","volume":"17","author":"MA Khan","year":"2023","unstructured":"Khan, M. A. et al. Molecular characterisation of X-ray crossc group 1 (XRCC1) gene and risk factors in senile cataract patients attending a tertiary care Hospital, Uttar Pradesh, India. J. Clin. Diagn. Res. 17 (2), AC06\u2013AC11 (2023).","journal-title":"J. Clin. Diagn. Res."},{"key":"35213_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1134\/S0006297920030049","volume":"85","author":"IA Vasil\u2019eva","year":"2020","unstructured":"Vasil\u2019eva, I. A., Moor, N. A. & Lavrik, O. I. Effect of human XRCC1 protein oxidation on the functional activity of its complexes with the key enzymes of DNA base excision repair. Biochem. (Mosc). 85, 288\u2013299 (2020).","journal-title":"Biochem. (Mosc)"},{"key":"35213_CR23","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s12253-017-0370-8","volume":"25","author":"B Smolarz","year":"2019","unstructured":"Smolarz, B. et al. Data on single nucleotide polymorphism of DNA repair genes and breast cancer risk from Poland. Pathol. Oncol. Res. 25, 1311\u20131317 (2019).","journal-title":"Pathol. Oncol. Res."},{"issue":"1\u20132","key":"35213_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrrev.2011.02.001","volume":"727","author":"G. Ginsberg","year":"2011","unstructured":"Ginsberg, G., Angle, K., Guyton, K. & Sonawane, B. Polymorphism in the DNA repair enzyme XRCC1: utility of current database and implications for human health risk assessment. Mutat. Res. 727 (1\u20132), 1\u201315 (2011).","journal-title":"Mutat. Res."},{"key":"35213_CR25","first-page":"12","volume":"6","author":"I Majsterek","year":"2012","unstructured":"Majsterek, I. et al. Role of oxidative DNA damage in pathogenesis of diabetic neuropathy. World Acad. Sci. Eng. Technol. 6, 12\u201315 (2012).","journal-title":"World Acad. Sci. Eng. Technol."},{"issue":"2","key":"35213_CR26","first-page":"90","volume":"66","author":"T Yesil-Devecioglu","year":"2019","unstructured":"Yesil-Devecioglu, T., Dayan, A., Demirtunc, R. & Sardas, S. Role of DNA repair genes XRCC3 and XRCC1 in predisposition to type 2 diabetes mellitus and diabetic nephropathy. Endocrinol. Diabetes Nutr. (Engl Ed). 66 (2), 90\u201398 (2019).","journal-title":"Endocrinol. Diabetes Nutr. (Engl Ed)"},{"issue":"32","key":"35213_CR27","doi-asserted-by":"publisher","first-page":"e11852","DOI":"10.1097\/MD.0000000000011852","volume":"97","author":"LJ Ye","year":"2018","unstructured":"Ye, L. J., Wang, Q., Wang, Y. & Zeng, Y. Association between XRCC1 single-nucleotide polymorphisms and susceptibility to nasopharyngeal carcinoma: an update meta-analysis. Medicine 97 (32), e11852\u201311859 (2018).","journal-title":"Medicine"},{"issue":"3","key":"35213_CR28","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s10549-020-05738-8","volume":"182","author":"NR Howlader","year":"2020","unstructured":"Howlader, N. R. et al. Genetic polymorphisms in DNA repair genes XRCC1 and 3 are associated with increased risk of breast cancer in Bangladeshi population. Breast Cancer Res. Treat. 182 (3), 739\u2013750 (2020).","journal-title":"Breast Cancer Res. Treat."},{"key":"35213_CR29","doi-asserted-by":"crossref","unstructured":"Meza-Espinoza, J. P., Peralta-Leal, V., Dur\u00e1n-Gonz\u00e1lez, J., Mac\u00edas-G\u00f3mez, N. & Bocanegra-Alonso, A. & Leal-Ugarte, E. XRCC1 R194W and R399Q Polymorphisms and Colorectal Cancer Risk in a Northeastern Mexican Population. Genet. Res. (Camb). 5565646 (2023). (2023).","DOI":"10.1155\/2023\/5565646"},{"issue":"7","key":"35213_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1177\/1535370219842791","volume":"244","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Interaction between XRCC 1 gene polymorphisms and diabetes on susceptibility to primary Open-Angle glaucoma. Exp. Biol. Med. (Maywood). 244 (7), 588\u2013592 (2019).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"35213_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.diabres.2018.07.025","volume":"144","author":"SH Assaad Khalil","year":"2018","unstructured":"Assaad Khalil, S. H. et al. Prevalence of type 2 diabetes mellitus in a sample of the adult population of Alexandria, Egypt. Diabetes Res. Clin. Prac. 144, 63\u201373 (2018).","journal-title":"Diabetes Res. Clin. Prac"},{"issue":"2","key":"35213_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.21608\/amj.2020.67803","volume":"49","author":"KM Hewedi","year":"2020","unstructured":"Hewedi, K. M., El-Adawy, A. F., Rezk, A. A. & Yassen, A. G. A. Risk factors associated with peripheral neuropathy in type II diabetic patients. Al-Azhar Med. J. 49 (2), 387\u2013398 (2020).","journal-title":"Al-Azhar Med. J."},{"key":"35213_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2337\/dc08-S055","volume":"31","author":"American Diabetes Association","year":"2008","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 31, 55\u201360 (2008).","journal-title":"Diabetes Care"},{"key":"35213_CR34","unstructured":"Lohman, T. G., Roche, A. F., & Martorell, R. (Eds.). (1988). Anthropometric standardization reference manual. Human Kinetics Books."},{"key":"35213_CR35","unstructured":"Hunter, L. W. & Narayan, J. H.& Report. Superintendent Government Print (1920)."},{"issue":"23","key":"35213_CR36","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1001\/jama.1993.03500230084034","volume":"269","author":"CL Johnson","year":"1993","unstructured":"Johnson, C. L. et al. Declining serum total cholesterol levels among US adults: the National health and nutrition examination surveys. Jama 269 (23), 3002\u20133008 (1993).","journal-title":"Jama"},{"issue":"3","key":"35213_CR37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5935\/1676-2444.20150024","volume":"51","author":"ASN Rodrigues","year":"2015","unstructured":"Rodrigues, A. S. N., Vanzeler, T. L. & Esp\u00edndola, G. O. Identification of polymorphisms of XRCC1 gene in patients with cancer in a City of Northern Brazil. J. Bras. Patol. Med. Lab. 51 (3), 138\u2013142 (2015).","journal-title":"J. Bras. Patol. Med. Lab."},{"issue":"1","key":"35213_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10072-007-0744-x","volume":"28","author":"S Do\u011fru-Abbaso\u011flu","year":"2007","unstructured":"Do\u011fru-Abbaso\u011flu, S. et al. The Arg194Trp polymorphism in DNA repair gene XRCC1 and the risk for sporadic late-onset alzheimer\u2019s disease. Neurol. Sci. 28 (1), 31\u201334 (2007).","journal-title":"Neurol. Sci."},{"key":"35213_CR39","unstructured":"R Core Team. R: A language and environment for statistical computing. (2023). Available at: https:\/\/www.r-project.org\/"},{"issue":"3","key":"35213_CR40","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/biomedicines11030981","volume":"11","author":"I Azarova","year":"2023","unstructured":"Azarova, I., Klyosova, E. & Polonikov, A. Single nucleotide polymorphisms of the RAC1 gene as novel susceptibility markers for neuropathy and microvascular complications in type 2 diabetes. Biomedicines 11 (3), 981 (2023).","journal-title":"Biomedicines"},{"issue":"12","key":"35213_CR41","doi-asserted-by":"publisher","first-page":"6429","DOI":"10.3390\/ijms25126429","volume":"25","author":"N Hajd\u00fa","year":"2024","unstructured":"Hajd\u00fa, N. et al. Genetic variants influence the development of diabetic neuropathy. Int. J. Mol. Sci. 25 (12), 6429 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"35213_CR42","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1038\/s41598-025-86143-3","volume":"15","author":"NM Bakr","year":"2025","unstructured":"Bakr, N. M., Hashim, N. A., Ibrahim, N. F. & Saadawy, S. F. Association between adiponectin single nucleotide polymorphisms and the risk of diabetic polyneuropathy. Sci. Rep. 15 (1), 3872 (2025).","journal-title":"Sci. Rep."},{"key":"35213_CR43","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/13813455.2010.551135","volume":"117","author":"L Pacal","year":"2011","unstructured":"Pacal, L. et al. Parameters of oxidative stress, DNA damage and DNA repair in type 1 and type 2 diabetes mellitus. Arch. Physiol. Biochem. 117, 222\u2013230 (2011).","journal-title":"Arch. Physiol. Biochem."},{"issue":"2","key":"35213_CR44","first-page":"326","volume":"7","author":"N Yigitbasi","year":"2018","unstructured":"Yigitbasi, N. et al. Investigation of DNA repair genes XPD and hOGG1 in type 2 diabetes mellitus. Med. Sci. 7 (2), 326\u2013329 (2018).","journal-title":"Med. Sci."},{"issue":"10","key":"35213_CR45","doi-asserted-by":"publisher","first-page":"e70014","DOI":"10.1111\/1753-0407.70014","volume":"16","author":"R Weinberg Sibony","year":"2024","unstructured":"Weinberg Sibony, R., Segev, O., Dor, S. & Raz, I. Overview of oxidative stress and inflammation in diabetes. J. Diabetes. 16 (10), e70014 (2024).","journal-title":"J. Diabetes"},{"key":"35213_CR46","doi-asserted-by":"publisher","first-page":"122","DOI":"10.20452\/pamw.626","volume":"119","author":"J Kasznicki","year":"2009","unstructured":"Kasznicki, J., Krupa, R., Blasiak, J. & Drzewoski, J. Association between polymorphisms of the DNA repair genes XRCC1 and hOGG1 and type 2 diabetes mellitus in the Polish population. Pol. Arch. Med. Wewn. 119, 122\u2013128 (2009).","journal-title":"Pol. Arch. Med. Wewn"},{"issue":"3","key":"35213_CR47","first-page":"249","volume":"12","author":"HS Al-Musawi","year":"2021","unstructured":"Al-Musawi, H. S., Jawad, M. A., Al-Terehi, M. N. & Kadhim, A. J. X-ray repair cross-complementing group 1 (Arg399Gln) genotyping in diabetes mellitus type 2 with hypertension. Int. J. Pharm. Qual. Assur. 12 (3), 249\u2013252 (2021).","journal-title":"Int. J. Pharm. Qual. Assur."},{"issue":"2","key":"35213_CR48","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.advms.2015.04.001","volume":"60","author":"A Merecz","year":"2015","unstructured":"Merecz, A. et al. Analysis of oxidative DNA damage and its repair in Polish patients with diabetes mellitus type 2: role in pathogenesis of diabetic neuropathy. Adv. Med. Sci. 60 (2), 220\u2013230 (2015).","journal-title":"Adv. Med. Sci."},{"issue":"1","key":"35213_CR49","first-page":"1","volume":"37","author":"P Narne","year":"2016","unstructured":"Narne, P., Ponnaluri, K. C., Siraj, M. & Ishaq, M. Association analysis of polymorphisms in genes related to oxidative stress in South Indian type 2 diabetic patients with retinopathy. Ophthalmic Genet. 37 (1), 1\u20138 (2016).","journal-title":"Ophthalmic Genet."},{"issue":"2","key":"35213_CR50","first-page":"194","volume":"19","author":"S Pahlavanneshan","year":"2016","unstructured":"Pahlavanneshan, S., Ahmadi, A., Boroumand, M., Sadeghian, S. & Behmanesh, M. Association of -77T > C and Arg194trp polymorphisms of XRCC1 with risk of coronary artery diseases in Iranian population. Iran. J. Basic. Med. Sci. 19 (2), 194\u2013200 (2016).","journal-title":"Iran. J. Basic. Med. Sci."},{"issue":"S2","key":"35213_CR51","first-page":"4125","volume":"6","author":"FK Rafeef","year":"2022","unstructured":"Rafeef, F. K. & Al-Husseini, R. M. A. H. Association of the genetic variants of XRCC1 DNA repair gene as genetic factors for breast cancer in Iraqi patients. Int. J. Health Sci. 6 (S2), 4125\u201314136 (2022).","journal-title":"Int. J. Health Sci."},{"issue":"3","key":"35213_CR52","first-page":"e1776","volume":"6","author":"N Mohtasham","year":"2023","unstructured":"Mohtasham, N., Najafi-Ghobadi, K. & Abbaszadeh, H. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: results from a systematic review and meta-analysis. Cancer Rep. (Hoboken). 6 (3), e1776 (2023).","journal-title":"Cancer Rep. (Hoboken)"},{"key":"35213_CR53","doi-asserted-by":"publisher","first-page":"394632024126526","DOI":"10.1177\/03946320241265263","volume":"38","author":"RA Ghorab","year":"2024","unstructured":"Ghorab, R. A., Fouad, S. H., Elsaadawy, Y., Hamdy, M. & Taha, S. I. Association of XRCC1 p. Arg194Trp gene polymorphism with the risk of hepatocellular carcinoma in HCV Egyptian population: A pilot case-control study. Int. J. Immunopathol. Pharmacol. 38, 3946320241265263 (2024).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"1","key":"35213_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.clbc.2012.09.019","volume":"13","author":"K Przybylowska-Sygut","year":"2012","unstructured":"Przybylowska-Sygut, K., Stanczyk, M., Kusinska, R., Kordek, R. & Majsterek, I. Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer. Clin. Breast Cancer. 13 (1), 61\u201368 (2012).","journal-title":"Clin. Breast Cancer"},{"key":"35213_CR55","doi-asserted-by":"crossref","unstructured":"Salimi, S. et al. XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of systemic lupus erythematosus in an Iranian population: a pilot study. Biomed. Res. Int. 492956 (2014). (2014).","DOI":"10.1155\/2014\/492956"},{"key":"35213_CR56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/jmg.31.2.89","volume":"31","author":"AO Wilkie","year":"1994","unstructured":"Wilkie, A. O. The molecular basis of genetic dominance. J. Med. Genet. 31, 89\u201398 (1994).","journal-title":"J. Med. Genet."},{"key":"35213_CR57","doi-asserted-by":"publisher","first-page":"e9379","DOI":"10.1371\/journal.pone.0009379","volume":"5","author":"AB Gjuvsland","year":"2010","unstructured":"Gjuvsland, A. B., Plahte, E., \u00c5dn\u00f8y, T. & Omholt, S. W. Allele interaction \u2013 Single locus genetics Meets regulatory biology. PLoS ONE. 5, e9379 (2010).","journal-title":"PLoS ONE"},{"issue":"1","key":"35213_CR58","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.yexcr.2014.08.027","volume":"329","author":"KW Caldecott","year":"2014","unstructured":"Caldecott, K. W. DNA single-strand break repair. Exp. Cell. Res. 329 (1), 2\u20138 (2014).","journal-title":"Exp. Cell. Res."},{"key":"35213_CR59","doi-asserted-by":"publisher","first-page":"100696","DOI":"10.1016\/j.mgene.2020.100696","volume":"24","author":"Y Mishchuk-Reka","year":"2020","unstructured":"Mishchuk-Reka, Y. et al. An association of XRCC1 codon 399 polymorphism (RS25487) with bladder and prostate cancer susceptibility in the Ukrainian population. Meta Gene. 24, 100696 (2020).","journal-title":"Meta Gene"},{"issue":"17","key":"35213_CR60","doi-asserted-by":"publisher","first-page":"9297","DOI":"10.3390\/ijms25179297","volume":"25","author":"IS Damarov","year":"2024","unstructured":"Damarov, I. S., Korbolina, E. E., Rykova, E. Y. & Merkulova, T. I. Multi-Omics analysis revealed the rSNPs potentially involved in T2DM pathogenic mechanism and Metformin response. Int. J. Mol. Sci. 25 (17), 9297 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"35213_CR61","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/jcb.29335","volume":"121","author":"W Cai","year":"2020","unstructured":"Cai, W. et al. New sights on the associations between the XRCC1 gene polymorphisms and hepatocellular carcinoma susceptibility. J. Cell. Biochem. 121 (2), 1005\u20131022 (2020).","journal-title":"J. Cell. Biochem."},{"key":"35213_CR62","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1158\/1055-9965.EPI-04-0793","volume":"14","author":"Z Hu","year":"2005","unstructured":"Hu, Z., Ma, H., Chen, F., Wei, Q. & Shen, H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol. Biomarkers Prev. 14, 1810\u20131818 (2005).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"35213_CR63","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/nep.12293","volume":"19","author":"P Narne","year":"2014","unstructured":"Narne, P., Ponnaluri, K. C., Siraj, M. & Ishaq, M. Polymorphisms in oxidative stress pathway genes and risk of diabetic nephropathy in South Indian type 2 diabetic patients. Nephrol. (Carlton Vic). 19, 623\u2013629 (2014).","journal-title":"Nephrol. (Carlton Vic)"},{"issue":"12","key":"35213_CR64","first-page":"OC10","volume":"11","author":"D Udayashankar","year":"2017","unstructured":"Udayashankar, D., Premraj, S. S., Mayilananthi, K. & Naragond, V. Applicability of Toronto clinical neuropathy scoring and its correlation with diabetic peripheral neuropathy: A prospective cross-sectional study. J. Clin. Diagn. Res. 11 (12), OC10\u2013OC13 (2017).","journal-title":"J. Clin. Diagn. Res."},{"issue":"02","key":"35213_CR65","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.37200\/IJPR\/V24I2\/PR200741","volume":"24","author":"M Basuki","year":"2020","unstructured":"Basuki, M. & Hamdan, M. Fidiana, Fadil, Noormainiwati. Toronto clinical neuropathy score and modified Toronto clinical neuropathy score diagnostic tests in distal diabetic sensorimotor polyneuropathy patients. Int. J. Psychosocial Rehabilitation. 24 (02), 4188\u20134197 (2020).","journal-title":"Int. J. Psychosocial Rehabilitation"},{"key":"35213_CR66","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jbmt.2023.11.030","volume":"37","author":"LRN Nogueira","year":"2024","unstructured":"Nogueira, L. R. N. et al. Behavior of neuropathy symptom score and neuropathy disability score in patients with and without peripheral diabetic neuropathy: A retrospective cohort study. J. Bodyw. Mov. Ther. 37, 76\u201382 (2024).","journal-title":"J. Bodyw. Mov. Ther."},{"key":"35213_CR67","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/jdi.12223","volume":"5","author":"D Bansal","year":"2014","unstructured":"Bansal, D. et al. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J. Diabetes Investig. 5, 714\u2013721 (2014).","journal-title":"J. Diabetes Investig"},{"key":"35213_CR68","doi-asserted-by":"crossref","unstructured":"Popescu, S. et al. Age as an independent factor for the development of neuropathy in diabetic patients. Clin. Interv. Aging. 11, 313\u2013318 (2016). (2016).","DOI":"10.2147\/CIA.S97295"},{"issue":"3","key":"35213_CR69","doi-asserted-by":"publisher","first-page":"592","DOI":"10.14336\/AD.2018.0618","volume":"10","author":"F Mao","year":"2019","unstructured":"Mao, F. et al. Age as an independent risk factor for diabetic peripheral neuropathy in Chinese patients with type 2 diabetes. Aging Dis. 10 (3), 592\u2013600 (2019).","journal-title":"Aging Dis."},{"issue":"12","key":"35213_CR70","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1001\/jamaneurol.2016.3745","volume":"73","author":"BC Callaghan","year":"2016","unstructured":"Callaghan, B. C. et al. Association between metabolic syndrome components and polyneuropathy in an obese population. JAMA Neurol. 73 (12), 1468\u20131476 (2016).","journal-title":"JAMA Neurol."},{"issue":"1","key":"35213_CR71","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12902-023-01526-9","volume":"24","author":"MA Karimi","year":"2024","unstructured":"Karimi, M. A. et al. Lipid variability and risk of microvascular complications in patients with diabetes: a systematic review and meta-analysis. BMC Endocr. Disord. 24 (1), 4 (2024).","journal-title":"BMC Endocr. Disord"},{"issue":"1","key":"35213_CR72","doi-asserted-by":"publisher","first-page":"e209538","DOI":"10.1212\/WNL.0000000000209538","volume":"103","author":"FPB Kristensen","year":"2024","unstructured":"Kristensen, F. P. B. et al. Lipid levels and risk of diabetic polyneuropathy in 2 Danish type 2 diabetes cohorts. Neurology 103 (1), e209538 (2024).","journal-title":"Neurology"},{"issue":"1","key":"35213_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-024-01543-1","volume":"17","author":"Y Jia","year":"2025","unstructured":"Jia, Y., Liu, G., Li, X., Duan, L. & Zhao, L. Relationship between BMI, indicators of lipid metabolism and diabetic neuropathy: a Mendelian randomization study. Diabetol. Metab. Syndr. 17 (1), 1 (2025).","journal-title":"Diabetol. Metab. Syndr."},{"key":"35213_CR74","first-page":"25","volume":"3","author":"NK Subbalakshmi","year":"2013","unstructured":"Subbalakshmi, N. K., Sathyanarayana, R. K. N., Adhikari, P. M. R. & Sheila, R. P. Influence of dyslipidemia on somatic neuropathy in type 2 diabetes mellitus. NUJHS 3, 25\u201330 (2013).","journal-title":"NUJHS"},{"issue":"2","key":"35213_CR75","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3126\/jdean.v2i2.22361","volume":"2","author":"S Rajbhandari","year":"2018","unstructured":"Rajbhandari, S., Hamid, F. S., Harris, N. & Tesfaye, S. Lipid profile as a predictor of neuropathy: the Sheffield prospective diabetes study. J. Diab Endo Assoc. Nepal. 2 (2), 47\u201351 (2018).","journal-title":"J. Diab Endo Assoc. Nepal."},{"issue":"6","key":"35213_CR76","doi-asserted-by":"publisher","first-page":"e0287373","DOI":"10.1371\/journal.pone.0287373","volume":"18","author":"KC Chang","year":"2023","unstructured":"Chang, K. C., Pai, Y. W., Lin, C. H., Lee, I. T. & Chang, M. H. The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus. PLoS One. 18 (6), e0287373 (2023).","journal-title":"PLoS One"},{"issue":"1","key":"35213_CR77","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1109\/JBHI.2016.2636665","volume":"21","author":"D Rav\u00ec","year":"2017","unstructured":"Rav\u00ec, D. et al. Deep learning for health informatics. IEEE J. Biomed. Health Inf. 21 (1), 4\u201321 (2017).","journal-title":"IEEE J. Biomed. Health Inf."},{"key":"35213_CR78","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.csbj.2016.12.005","volume":"15","author":"I Kavakiotis","year":"2017","unstructured":"Kavakiotis, I. et al. Machine learning and data mining methods in diabetes research. Comput. Struct. Biotechnol. J. 15, 104\u2013116 (2017).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"35213_CR79","doi-asserted-by":"crossref","unstructured":"Shiren, Y., Jiangnan, Y., Xinhua, Y. & Xinye, N. Interpretable prediction model for assessing diabetes complication risks in Chinese sufferers. Diabetes Res. Clin. Pract. 209, 111560 (2024). (2024).","DOI":"10.1016\/j.diabres.2024.111560"},{"issue":"1","key":"35213_CR80","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12911-024-02595-z","volume":"24","author":"Y Wu","year":"2024","unstructured":"Wu, Y. et al. Interpretable machine learning models for detecting peripheral neuropathy and lower extremity arterial disease in diabetics: an analysis of critical shared and unique risk factors. BMC Med. Inf. Decis. Mak. 24 (1), 200 (2024).","journal-title":"BMC Med. Inf. Decis. Mak."},{"issue":"1","key":"35213_CR81","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12911-023-02232-1","volume":"23","author":"X Lian","year":"2023","unstructured":"Lian, X. et al. Study on risk factors of diabetic peripheral neuropathy and establishment of a prediction model by machine learning. BMC Med. Inf. Decis. Mak. 23 (1), 146 (2023).","journal-title":"BMC Med. Inf. Decis. Mak."},{"issue":"19","key":"35213_CR82","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.3390\/jcm10194576","volume":"10","author":"D. Y. Shin","year":"2021","unstructured":"Shin, D. Y., Lee, B., Yoo, W. S., Park, J. W. & Hyun, J. K. Prediction of diabetic sensorimotor polyneuropathy using machine learning techniques. J. Clin. Medi. 10 (19), 4576 (2021).","journal-title":"J. Clin. Medi"},{"key":"35213_CR83","first-page":"55","volume":"2","author":"MO G\u00d6K\u00c7E","year":"2017","unstructured":"G\u00d6K\u00c7E, M. O. et al. Association of the XRCC1 and XRCC3 gene variants with type 2 diabetes mellitus. Turkish J. Mol. Biology Biotechnol. 2, 55\u201362 (2017).","journal-title":"Turkish J. Mol. Biology Biotechnol."},{"issue":"7","key":"35213_CR84","first-page":"1559","volume":"21","author":"SJ Guo","year":"2017","unstructured":"Guo, S. J., Zhou, Y. T., Liu, W. Y., Zuo, Q. N. & Li, X. H. The polymorphism of XRCC1 and coronary artery disease risk: a meta-analysis. Eur. Rev. Med. Pharmacol. Sci. 21 (7), 1559\u20131567 (2017).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35213-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35213-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35213-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:23:27Z","timestamp":1779200607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35213-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35213"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35213-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"27 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article the affiliation ' Department of Clinical and Chemical Pathology, Institute of Medical Research and Clinical Studies, National Research Centre, Cairo, Egypt,' was incorrectly given as \" Department of Clinical Pathology, Institute of Medical Research and Clinical studies, National Research Centre, Dokki, Giza, Egypt.\u201d The original article has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4815"}}